Athira Pharma to effect 10-for-1 reverse stock split on Sep 17 to meet Nasdaq minimum bid price

LeonaBio, Inc.

Effective Sept 17 at 5pm ET; shares start trading split-adjusted on Sep 18 under ticker ATHA.
Every 10 pre-split shares convert to 1; authorized common shares reduced from 900M to 90M.
Purpose: increase share price to comply with Nasdaq's $1.00 minimum bid requirement.
Fractional shares paid in cash; CUSIP changes to 04746L203.
No action needed by book-entry or street-name holders; Computershare is exchange agent.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.